US Oncology Director of Finance Salaries in Tampa, FL | Comparably
US Oncology operates a network of integrated community-based oncology practices that provides cancer care services in the United States. read more
EMPLOYEE
PARTICIPANTS
80
TOTAL
RATINGS
550

US Oncology Director of Finance Salaries in Tampa, FL

The average US Oncology Director of Finance in Tampa, FL earns an estimated $147,018 annually. US Oncology's Director of Finance compensation is $14,998 less than the US average for a Director of Finance.

In Tampa, FL, The Finance Department at US Oncology earns $2,016 more on average than the IT Department.

Last updated 9 months ago.

$30k
$74k
$117k
$159k
$350k
$600k
$147,018
Average Compensation
$147,018
avg. base

Director of Finance Salaries at US Oncology

In Tampa, FL, Directors of Finance earn $25,791 more than Accounting Managers.

Accounting Manager
$121k*
Senior Accountant
$92k*
Financial Analyst
$87k*
Accountant
$71k*
Business Analyst
$61k*
* estimated salary

Compensation at US Oncology by Department

In Tampa, FL, The Finance Department averages $2,016 more than the IT Department, and $29,537 less than the HR Department

HR
$110,119 Avg. total comp.
+$30k
Finance
$80,582 Avg. total comp.
IT
$78,566 Avg. total comp.
-$2k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to US Oncology reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to US Oncology reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at US Oncology Rate Their Compensation

The majority of Directors of Finance at US Oncology believe they're compensated fairly. 50% of Directors of Finance at US Oncology say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at US Oncology

×
Rate your company